Physician profile
Daniel Sohn
NPI 1710966254
$26,236.06
in general payments reported to CMS, 2019-2025
30 companies · $6,031 in 2025
The $6,031 reported for 2025 was more than what 84% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $427 · 2021: $79.79 · 2022: $1,643 · 2023: $454 · 2024: $3,383 · 2025: $6,031.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,645 · Food and Beverage: $4,156 · Education: $67.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,644.77 |
| Food and Beverage | $4,155.94 |
| Education | $67.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $15,135.34 | 2019-2025 | Spherika, Gmk Sphere, Gmk Efficiency |
| Zimmer Biomet Holdings, INC. | $2,918.42 | 2020-2025 | Avenir, Oxford, Persona |
| Arthrex, INC. | $2,520.91 | 2022-2025 | |
| Zak Ortho | $1,489.50 | 2025 | |
| Stryker Corporation | $1,486.57 | 2020-2025 | Mako, Aequalis Flex Revive, Trident |
| Medtronic USA, INC. | $642.96 | 2019-2020 | |
| Medwest Associates | $575.00 | 2019 | |
| Heron Therapeutics, INC. | $253.73 | 2025 | Zynrelef |
| Lightbody Medical Technologies INC | $224.99 | 2023 | |
| Depuy Synthes Sales INC. | $149.84 | 2020-2024 | Na |
| Endo Pharmaceuticals INC. | $144.63 | 2019-2020 | |
| Sentynl Therapeutics, INC. | $125.93 | 2019 | |
| Orthofix Medical, INC. | $75.36 | 2019-2025 | Physio-Stim |
| Next Science LLC | $60.48 | 2020 | |
| Smith+Nephew, INC. | $55.89 | 2019-2025 | Pico 7 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $44.33 | 2019-2025 | Biobrace 23mm |
| Avanos Medical | $43.12 | 2019 | |
| Dynasplint Systems INC. | $42.17 | 2025 | Dynasplint |
| Vertex Pharmaceuticals Incorporated | $38.63 | 2025 | |
| Amgen INC. | $32.08 | 2019-2023 | Evenity, Prolia |
| Bioventus LLC | $24.80 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $20.20 | 2019 | |
| Pacira Therapeutics, INC. | $18.82 | 2019 | |
| Mallinckrodt Enterprises LLC | $18.56 | 2019 | |
| Davol INC. | $18.34 | 2025 | Arista |
| Ethicon US, LLC | $16.73 | 2024 | Stratafix, Ethicon, Vistaseal |
| Janssen Pharmaceuticals, INC | $16.40 | 2020 | |
| Fx Shoulder Solutions, INC | $15.14 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.48 | 2022 | |
| Vericel Corporation | $12.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Sohn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.